Associate Clinical Professor of Neurology, Brown University
Neurology
Dr. Stephen P. Salloway, MD
|
|
Give Review
Stephen P. Salloway practices Neurology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He over the years received 1 awards: "Regional Top Doctor". Stephen Salloway is a published physician. He has 99 papers published. The most current publication "CADASIL syndrome: a genetic form of vascular dementia." He accepts Medicare.
Publications
- Lowering the Floor on Trail Making Test Part B: Psychometric Evidence for a New Scoring Metric.
- Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial.
- Early behavioural changes in familial Alzheimer's Disease in the Dominantly Inherited Alzheimer Network.
- Factors associated with the onset and persistence of post-lumbar puncture Headache.
- Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.
- Building a roadmap for developing combination therapies for Alzheimer's Disease.
- Charting a path toward combination therapy for Alzheimer's Disease.
- Functional connectivity in autosomal dominant and late-onset Alzheimer Disease.
- Advancing research diagnostic criteria for Alzheimer's Disease: the IWG-2 criteria.
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease.
- Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's Disease.
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer's Disease.
- Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial.
- The pattern of atrophy in familial Alzheimer Disease: Volumetric MRI results from the DIAN study.
- Successful management of severe neuroinvasive eastern equine encephalitis.
- Impaired default network functional connectivity in autosomal dominant Alzheimer Disease.
- MR Imaging Features of Amyloid-Related Imaging AbNormalities.
- The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier).
- Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development.
- Potential impact of amyloid imaging on diagnosis and intended management in patients with Progressive cognitive decline.
- Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer Disease.
- A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate alzheimer's Disease.
- Deep Brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression.
- Quantitative tractography metrics of white matter integrity in diffusion-tensor MRI.
- Three-year outcomes in deep Brain stimulation for highly resistant obsessive-compulsive disorder.
- Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.
- Effect of APOE genotype on microvascular basement membrane in Alzheimer''s Disease.
- The impact of behavioral symptoms on activities of daily living in patients with Dementia.
- Assessment of treatment outcomes in neuropsychiatry: a report from the Committee on Research of the American Neuropsychiatric Association.
- Multiple sclerosis presenting as major depression: a diagnosis suggested by MRI scan but not CT scan.
- Opiate withdrawal presenting as posttraumatic stress disorder.
- Finding meaning: an alternative paradigm for Alzheimer's Disease family caregivers.
- Skeptics and enthusiasts in neuropsychiatry.
- Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals.
- Alteration of intention and self-initiated action associated with bilateral anterior cingulotomy.
- Infection control programs for behavioral health care settings.
- Pharmacologic efficacy in neuropsychiatry: a review of placebo-controlled treatment trials. A report of the ANPA Committee on Research.
- CADASIL syndrome: a genetic form of vascular Dementia.
- Recollection of childhood sexual abuse following endotracheal intubation.
- The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric Association.
- Memory processes in depressed geriatric patients with and without subcortical hyperintensities on MRI.
- Paroxysmal limbic Disorders in neuropsychiatry.
- The limbic System: an anatomic, phylogenetic, and clinical perspective.
- The diagnosis and treatment of post-stroke depression.
- Neuropsychiatric factors in the illusion of visitors among geriatric patients: a case series.
- Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association.
- Subcortical hyperintensities on MRI and activities of daily living in geriatric depression.
- Clinical-pathological case conference: depression, behavior change, and subcortical Dementia in a 57-year-old woman.
- Botulinum toxin for refractory vocal tics.
- Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.
- MRI and neuropsychological differences in early- and late-life-onset geriatric depression.
- Neuropsychiatric aspects of movement Disorders.
- Case conference: behavior change, hallucinations, and memory loss in a 25-year-old man.
- Neuropsychiatric aspects of depression.
- Subcortical Disease and neuropsychiatric illness.
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer Disease.
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer Disease.
- Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
- Galantamine treatment of vascular Dementia: a randomized trial.
- Spontaneous lobar haemorrhage in CADASIL.
- Deep Brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.
- Treatment strategies for patients with dysexecutive syndromes.
- Diagnosis and treatment of patients with "frontal lobe" syndromes.
- Neuropsychiatric correlates and treatment of lenticulostriatal Diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, a...
- Prolonged postictal encephalopathy in two patients with clozapine-induced seizures.
- The use of herbal alternative medicines in neuropsychiatry. A report of the ANPA Committee on Research.
- Assessing visuoconstructional performance in AD, MCI and Normal elderly using the Beery Visual-Motor Integration Test.
- Efficacy and tolerability of donepezil in vascular Dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
- Executive dysfunction and apathy predict functional impairment in Alzheimer Disease.
- Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer Disease.
- MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.
- Dementia with Lewy bodies: a diagnostic and treatment challenge.
- The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients.
- Amyloid-related imaging abnormalities in patients with Alzheimer's Disease treated with bapineuzumab: a retrospective analysis.
- Taking the next steps in the treatment of Alzheimer's Disease: Disease-modifying agents.
- Current and future treatments for Alzheimer's Disease.
- The long-term efficacy and tolerability of donepezil in patients with vascular Dementia.
- Alzheimer''s Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned?
- Identifying amnestic mild cognitive impairment in primary care: a feasibility study.
- Glial vascular degeneration in CADASIL.
- Amyloid-β associated cortical thinning in clinically Normal elderly.
- New lessons from the Alzheimer's Disease Neuroimaging Initiative.
- Autosomal-dominant Alzheimer's Disease: a review and proposal for the prevention of Alzheimer's Disease.
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's Disease: A 24-week, randomized, double...
- Randomized, placebo-controlled, clinical trial of donepezil in vascular Dementia: differential effects by hippocampal size.
- Evidence for the validity of the American Medical Association's caregiver self-assessment questionnaire as a screening measure for depression.
- Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study.
- Introduction: the prevalence of Alzheimer's Disease--a growing crisis.
- Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
- Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype.
- Disease-modifying therapies in Alzheimer's Disease.
- Alzheimer Disease: time to improve its diagnosis and treatment.
- Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI.
- Recommendations for best practices in the treatment of Alzheimer's Disease in managed care.
- Assessing motor and cognitive regulation in AD, MCI, and controls using the Behavioral Dyscontrol Scale.
- Improving the diagnosis and treatment of Alzheimer's Disease.
- Perspectives on depression, mild cognitive impairment, and cognitive decline.
- Donepezil in vascular Dementia: combined analysis of two large-scale clinical trials.
Schools
Stanford University School Of Medicine
Yale University
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Yale-New Haven Hospital -
Stanford University School of Medicine
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1891701116 | |
| NPPES Provider LastName | SALLOWAY | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 029064800 | |
| NPPES Provider State | RI | |
| Specialty Description | Neurology | |
| Total Claim Count | 1673.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891701116 |
| Last Name Of The Provider | SALLOWAY |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
|
Dr. Joel Kaufman, MD |
|
|
Dr. Rajiv Magge, MD |
|
|
Dr. Deena Kuruvilla, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roderick Elias, MD |
|
|
Dr. Andrew J. Bouley, MD |
|
|
Dr. Matthew M. Sochat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher James, MD |
|
|
Dr. Jacob R. Berger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Molly Tracy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie L. Roth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry Querfurth, MD
This Doctor is OpenDoctor Recommended.
|